All Stories

  1. No reduction of radiation dose following the introduction of dose–area product measurement in endoscopic retrograde cholangiopancreatography
  2. A Rule for Determining Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease
  3. Biodegradable stent placement before neoadjuvant chemoradiotherapy as a bridge to surgery in patients with locally advanced esophageal cancer
  4. A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines
  5. A new fully covered metal stent with anti-migration features for the treatment of malignant dysphagia
  6. A novel lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic fluid collections: a prospective cohort study
  7. Surveillance of Barrett's Esophagus and Mortality from Esophageal Adenocarcinoma: A Population-Based Cohort Study
  8. Functional outcome of patients treated for radiation-induced complete esophageal obstruction after successful endoscopic recanalization (with video)
  9. Tu1289 The Long-Term Impact of Autoimmune Pancreatitis: Treatment Outcome, Survival, Pancreatic Function, and Quality of Life
  10. Tu1290 Long-Term Relapse Rates of Type 1 and 2 Autoimmune Pancreatitis
  11. A Comparative Study of Diagnostic Scoring Systems for Autoimmune Pancreatitis
  12. 738 EUS-Guided Drainage With a Large Diameter Metal Stent Is a Safe Treatment for Acute Cholecystitis in High-Risk Surgical Patients
  13. Mo1397 Clinical Impact of Liquid-Based or Cell Block Preparation of Residual Material After Analysis of Cytological Smears in Endoscopic Ultrasound-Guided Fine-Needle Aspiration
  14. Consistency of a high-grade dysplasia diagnosis in Barrett's oesophagus: A Dutch nationwide cohort study
  15. The role of routine preoperative EUS when performed after contrast enhanced CT in the diagnostic work-up in patients suspected of pancreatic or periampullary cancer
  16. Comparable Efficacy of Low- Versus High-Dose Induction Corticosteroid Treatment in Autoimmune Pancreatitis
  17. Upper gastrointestinal tumors
  18. Multicenter experience with performance of ERCP in patients with an indwelling duodenal stent
  19. High proximal migration rate of a partially covered “big cup” duodenal stent in patients with malignant gastric outlet obstruction
  20. In vitro evaluation of the radial and axial force of self-expanding esophageal stents
  21. Symptoms associated with finding colorectal cancer during colonoscopy
  22. Toll-like receptor 4 activation in Barrett’s esophagus results in a strong increase in COX-2 expression
  23. Endoscopic ultrasonography-guided drainage is an effective and relatively safe treatment for peripancreatic fluid collections in a cohort of 108 symptomatic patients
  24. Self-expandable metal stents for endoscopic ultrasound-guided drainage of peripancreatic fluid collections
  25. Su1447 Prevalence and Natural History of Low-Grade Dysplasia in Patients With Barrett's Esophagus
  26. Tu1308 Risk of Complications Associated With PEG Placement May Be Higher With the Pull Technique Than With the Push Technique
  27. Su1522 Safety and Efficacy of a Biodegradable Stent During Neoadjuvant Therapy in Patients With Advanced Esophageal Cancer (Esnebio)
  28. Su1502 A New Fully Covered Metal Stent (Hanaro-Utrecht Stent) for the Treatment of Malignant Esophageal Strictures: a Prospective Follow-up Study
  29. Su1429 A Fully Covered Self-Expandable Metal Stent, Niti-S, for Benign Biliary Strictures: a Prospective Multi-Center Follow-up Study
  30. CT-Colonography After Incomplete Colonoscopy
  31. Corrigendum: Endoscopic Clip-Assisted Feeding Tube Placement Reduces Repeat Endoscopy Rate: Results from a Randomized Controlled Trial
  32. Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease
  33. Biodegradable stent placement in the esophagus
  34. Barrett's esophagus, reflux esophagitis, and eosinophilic esophagitis
  35. Sentinel lymph node mapping in colon cancer using radiocolloid as a single tracer
  36. Endoscopic Clip-Assisted Feeding Tube Placement Reduces Repeat Endoscopy Rate: Results from a Randomized Controlled Trial
  37. Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series
  38. Tu1576 Single and Sequential Biodegradable Stent Placement for Refractory Benign Esophageal Strictures: A Prospective Follow-Up Study
  39. A new fully covered metal stent for the treatment of benign and malignant dysphagia: a prospective follow-up study
  40. Tu1579 Cryospray Ablation Using Pressurized Carbon Dioxide Gas for the Ablation of Barrett's Esophagus With Early Neoplasia
  41. Tu1727 Nasoenteral Feeding Tube Placement Using Ultra-Thin Endoscopy in Daily Clinical Practice Is Associated With Low Success Rates
  42. Tu1594 Technical Aspects of Endoscopic Removal of Stents Placed for Benign Esophageal Diseases
  43. Tu1539 EUS-Guided Drainage Is an Effective Treatment for the Majority of Symptomatic Peripancreatic Fluid Collections
  44. 1138 Surveillance Is Associated With a Lower Tumor Stage and Increased Survival in Barrett's Esophagus Patients Diagnosed With Esophageal Adenocarcinoma
  45. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis
  46. Fully covered self-expandable metal stents (SEMS), partially covered SEMS and self-expandable plastic stents for the treatment of benign esophageal ruptures and anastomotic leaks
  47. Risk Factors for Rectal Stump Cancer in Inflammatory Bowel Disease
  48. Technical feasibility and safety of a new, implantable reflux control system to prevent gastroesophageal reflux in patients with stents placed through the lower esophageal sphincter (with video)
  49. Endoscopic Management of Difficult or Recurrent Esophageal Strictures
  50. Stent placement for esophageal strictures: an update
  51. A Comparison of Temporary Self-Expanding Plastic and Biodegradable Stents for Refractory Benign Esophageal Strictures
  52. Predictors of survival in patients with malignant gastric outlet obstruction: A patient-oriented decision approach for palliative treatment
  53. Location in the Right Hemi-Colon Is an Independent Risk Factor for Delayed Post-Polypectomy Hemorrhage: A Multi-Center Case–Control Study
  54. Sa1548 Temporary Self-Expanding Plastic Stent Placement or Biodegradable Stent Placement for Refractory Benign Esophageal Strictures: A Comparison
  55. Su1482 A New Fully Covered Metal Stent (Wallflex) to Treat Benign and Malignant Esophageal Disorders: A Prospective Follow-Up Study
  56. Su1487 Prevention of Reflux Using the Retrofit Reflux Control Device in Patients With Distally Placed Esophageal Stents: A Technical Assessment
  57. 168 Sampling Bias/Misclassification in the Diagnosis of High-Grade Dysplasia in Barrett's Esophagus: A Dutch Population-Based Study
  58. Sa1445 Low Impact of Staging EUS for Determining Surgical Resectability of Esophageal Cancer
  59. 1178 Factors Affecting Miss Rate of Polyps During Colonoscopy: Results From a Prospective, Multicenter Back-to-Back Colonoscopy Study
  60. A new partially covered metal stent for palliation of malignant dysphagia: a prospective follow-up study
  61. Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study
  62. Stents for benign esophageal strictures
  63. Esophageal strictures, tumors, and fistulae: alternative techniques for palliating primary esophageal cancer
  64. Endoscopic magnetic gastroenteric anastomosis for palliation of malignant gastric outlet obstruction: a prospective multicenter study
  65. M1941 Expression of Proteins Involved in Carcinogenic Pathways in Patients With Primary Sclerosing Cholangitis and Colitis-Associated Colorectal Cancer
  66. T1225 CT-Colography After Incomplete Colonoscopy: What is the Diagnostic Yield?
  67. M1940 Colorectal Cancer Microsatellite Status in Patients With Primary Sclerosing Cholangitis and Concurrent Inflammatory Bowel Disease
  68. W1874 Differential Expression and Activity of Toll-Like Receptor 2 and 4 in Barrett's Esophagus and Esophageal Adenocarcinoma
  69. S1636 MicroRNA-145 is Highly Expressed in Barrett's Esophagus, Induces a Decrease in Cell Proliferation and Targets Gata6 in Esophageal Squamous Epithelial Cells
  70. S1067 MicroRNA-143, 145, 192, 194, 215 and Components of the miRNA Processing Apparatus and Gene Silencing Complex are Preferentially Expressed in Barrett's Esophagus Compared to Normal Squamous Epithelium and Esophageal Adenocarcinoma
  71. 17 Prior Endoscopy and Follow-up Strategies in Patients With High Grade Dysplasia in Barrett's Esophagus: A Dutch Population-Based Study
  72. M1513: Single-Center Evaluation of the Third Eye Retroscope: A Back-to-Back Study
  73. T1578: A New Partially Covered Metal Stent (Wallflex) for the Palliation of Malignant Dysphagia: A Prospective Follow-up Study
  74. T1579: Covered Self-Expandable Stents for the Treatment of Benign Esophageal Perforations and Anastomotic Leaks
  75. T1587: The Stent-in-Stent Technique Is Effective and Safe for Removal of Embedded Esophageal Stents
  76. A new fully covered stent with antimigration properties for the palliation of malignant dysphagia: a prospective cohort study
  77. A new metal stent with a controlled-release system for palliation of malignant dysphagia: a prospective, multicenter study
  78. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial
  79. Performance of EUS-FNA for mediastinal lymphadenopathy: impact on patient management and costs in low-volume EUS centers
  80. Plastic or metal stents for benign extrahepatic biliary strictures: a systematic review
  81. Stent placement in esophageal cancer as a bridge to surgery
  82. Endoscopic and pathological aspects of colitis-associated dysplasia
  83. Stenting Gastro-Oesophageal Tumours
  84. S1970 Are MicroRNA-215 and 199a-5p Potentially Useful Biomarkers in the Development of Barrett's Esophagus and Esophageal Adenocarcinoma?
  85. Plastic or Metal Stents for Benign Biliary Obstructions? A Systematic Review of the Literature
  86. Benign Refractory Esophageal Strictures: Preliminary Results from the BEST (Biodegradable Esophageal STent) Study
  87. Endoscopic Magnetic Anastomosis Device for Palliation of Malignant Gastric Outlet Obstruction: Short Term Results of a Prospective Multicenter Study
  88. Factors Predicting Patency of Stents Placed for Malignant Biliary Strictures: A Cox Regression Analysis
  89. Gastrojejunostomy Versus Duodenal Stent Placement for the Palliation of Malignant Gastric Outlet Obstruction: Multicenter Randomized Trial
  90. High Definition Chromoendoscopy for the Detection of Rectal Aberrant Crypt Foci
  91. A New Design Fully Covered Metal Stent (SX-ELLA Stent Esophageal HV) for the Palliation of Malignant Dysphagia: A Prospective Follow-Up Study
  92. A New Metal Stent with Controlled Release System (Evolution) for the Palliation of Malignant Dysphagia: A Prospective Follow-Up Study
  93. High lifetime risk of cancer in primary sclerosing cholangitis
  94. Removable Self-Expanding Plastic Esophageal Stent as a Continuous, Non-Permanent Dilator in Treating Refractory Benign Esophageal Strictures: A Prospective Two-Center Study
  95. Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study
  96. 915 Wnt-Pathway Activation in Early IBD-Associated Colorectal Carcinogenesis: A Biomarker for Colonic Surveillance
  97. 199 Colonoscopic Surveillance in Inflammatory Bowel Disease Improves Survival After Colorectal Cancer Diagnosis
  98. 194 A Comprehensive Meta-Analysis of the Risk of Colorectal Cancer in Ulcerative Colitis and Crohn's Disease
  99. 197 More Right-Sided IBD-Associated Colorectal Cancer in Patients with Primary Sclerosing Cholangitis
  100. Autoimmune pancreatocholangitis: A series of ten patients
  101. Transjugular Intrahepatic Portosystemic Shunts: Long-term Patency and Clinical Results in a Patient Cohort Observed for 3–9 Years
  102. Scienresing panereatocholangitis, a series of ten patients
  103. No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study
  104. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis
  105. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitisNote
  106. Management of osteoporosis in primary biliary cirrhosis
  107. Prevention and treatment of osteoporosis in primary biliary cirrhosis
  108. Progress and novel discoveries in biliary tract diseases
  109. Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population